|
Panacea Biotec Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2385.10 Cr.
|
P/BV
|
2.85
|
Book Value (Rs.)
|
136.66
|
|
52 Week High/Low (Rs.)
|
647/292
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.88 | -1.37 | -0.19 | -5.43 | 175.98 |
| Diluted EPS (Rs.) | -0.88 | -1.37 | -0.19 | -5.43 | 175.98 |
| Cash EPS (Rs.) | 4.23 | 4.26 | 5.75 | 0.87 | 183.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 136.19 | 132.76 | 133.94 | 133.63 | 138.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 136.19 | 132.76 | 133.94 | 133.63 | 138.09 |
| Revenue From Operations / Share (Rs.) | 104.37 | 91.28 | 91.29 | 75.09 | 107.96 |
| PBDIT / Share (Rs.) | 2.00 | -0.85 | 0.93 | -7.56 | -0.47 |
| PBIT / Share (Rs.) | -3.40 | -6.54 | -5.06 | -13.95 | -7.60 |
| PBT / Share (Rs.) | -1.20 | -1.30 | 0.24 | 2.09 | 236.54 |
| Net Profit / Share (Rs.) | -1.17 | -1.42 | -0.24 | -5.51 | 175.98 |
| NP After MI And SOA / Share (Rs.) | -0.87 | -1.37 | -0.19 | -5.43 | 175.98 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.91 | -0.93 | 1.02 | -10.06 | -0.43 |
| PBIT Margin (%) | -3.25 | -7.16 | -5.53 | -18.57 | -7.04 |
| PBT Margin (%) | -1.15 | -1.42 | 0.26 | 2.78 | 219.10 |
| Net Profit Margin (%) | -1.11 | -1.55 | -0.26 | -7.33 | 163.01 |
| NP After MI And SOA Margin (%) | -0.83 | -1.49 | -0.20 | -7.22 | 163.01 |
| Return on Networth / Equity (%) | -0.64 | -1.02 | -0.14 | -4.04 | 126.99 |
| Return on Capital Employeed (%) | -2.27 | -4.34 | -3.32 | -9.09 | -4.75 |
| Return On Assets (%) | -0.42 | -0.64 | -0.09 | -2.61 | 60.47 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| Asset Turnover Ratio (%) | 0.50 | 0.44 | 0.44 | 0.30 | 0.24 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.47 | 1.49 | 1.57 | 1.71 | 1.30 |
| Quick Ratio (X) | 0.91 | 0.90 | 0.99 | 1.10 | 1.03 |
| Inventory Turnover Ratio (X) | 3.15 | 2.86 | 1.11 | 1.02 | 1.14 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.02 | -1.36 | 1.60 | -10.43 | -0.01 |
| Interest Coverage Ratio (Post Tax) (%) | -3.41 | -10.54 | -9.48 | -29.74 | -2.31 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1768.73 | 2610.05 | 620.65 | 454.38 | 355.93 |
| EV / Net Operating Revenue (X) | 2.76 | 4.67 | 1.11 | 0.98 | 0.53 |
| EV / EBITDA (X) | 144.50 | -496.96 | 108.22 | -9.81 | -122.86 |
| MarketCap / Net Operating Revenue (X) | 2.84 | 4.83 | 1.33 | 1.44 | 1.37 |
| Price / BV (X) | 2.17 | 3.32 | 0.90 | 0.80 | 1.07 |
| Price / Net Operating Revenue (X) | 2.84 | 4.83 | 1.33 | 1.44 | 1.37 |
| EarningsYield | 0.00 | 0.00 | 0.00 | -0.05 | 1.19 |
